Clinical Trial Update: EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA

View source ↗

Summary

A completed clinical trial update reports on detecting EGFR delEx19 and KRAS exon 2 mutations in EBUS-TBNA samples from patients with metastatic lung adenocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: University Hospital, Essen | Conditions: Lung Adenocarcinoma Metastatic | Status: COMPLETED